Cardinal Health director sells 4,000 shares

Cardinal Health director Patricia Hemingway Hall reported a sale of company stock.

Accepted by SEC EDGAR 02/10/2026 - 04:13 PM EST

(Neutral)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Cardinal Health director Patricia Hemingway Hall reported a sale of company stock. On 02/06/2026, she sold 4,000 Common Shares of Cardinal Health at a price of $229.72 per share. After this transaction, she directly holds 28,264 Cardinal Health common shares.

Insider Trade Summary

Net Seller: 4,000 shares

Net Sell 1 txn

Insider Hall Patricia Hemingway

Role Director

Sold 4,000 shs ($919K)

Share of Position Sold 12.4%

Type	Security	Shares	Price	Value
Sale	Common Shares	4,000	$229.72	$919K

Holdings After Transaction: Common Shares — 28,264 shares (Direct)

Holdings Before and After: Common Shares, 32,264 to 28,264 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cardinal Health (CAH) disclose in this Form 4?

Cardinal Health disclosed that director Patricia Hemingway Hall sold 4,000 Common Shares on 02/06/2026 at $229.72 per share. This transaction was reported as a direct ownership change and is recorded in a Form 4 insider trading report.

Who is the insider involved in the latest Cardinal Health (CAH) Form 4 filing?

The insider is Patricia Hemingway Hall, a director of Cardinal Health. She reported a sale of 4,000 Common Shares on 02/06/2026, executed at a price of $229.72 per share, with the shares held in a direct ownership capacity.

How many Cardinal Health (CAH) shares did Patricia Hemingway Hall sell and at what price?

Patricia Hemingway Hall sold 4,000 Cardinal Health Common Shares in a single reported transaction. The sale occurred on 02/06/2026 at a reported transaction price of $229.72 per share, according to the Form 4 filing data.

How many Cardinal Health (CAH) shares does Patricia Hemingway Hall own after this transaction?

Following the sale, Patricia Hemingway Hall beneficially owns 28,264 Cardinal Health Common Shares. The Form 4 indicates this as her total directly held position after the reported 4,000-share sale on 02/06/2026 at $229.72 per share.

What type of security was involved in Patricia Hemingway Hall’s Cardinal Health (CAH) Form 4 transaction?

The transaction involved Cardinal Health Common Shares, classified as a non-derivative security. She sold 4,000 Common Shares at $229.72 per share, and no derivative securities transactions were reported in the Form 4’s derivative securities table.

Was Patricia Hemingway Hall’s Cardinal Health (CAH) transaction reported as direct or indirect ownership?

The 4,000-share sale by Patricia Hemingway Hall was reported under direct ownership. The Form 4 lists the ownership form as “D” for direct, with 28,264 Cardinal Health Common Shares directly beneficially owned following the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hall Patricia Hemingway

(Last)

(First)

(Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN

43017

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	02/06/2026		S		4,000	D	$229.72	28,264	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	/s/ Laura C. Dhaliwal, Attorney-in-fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR